Barrett's esophagus: better risk prediction and its effect on quality of life
Part of Cancer, Digestive system clinical trials.
This trial tests a new risk model to predict if early Barrett's esophagus-related cancer may return. It also looks at how telling patients their risk affects their quality of life and fear of cancer. If you have Barrett's with a small, early cancer, this study may help decide the best follow-up plan for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Barrett's esophagus and are having an endoscopy for suspected early-stage esophageal cancer (T1).
- You are 18 years or older.
- You are willing to be randomly assigned to different follow-up schedules based on a biomarker test.
- You have no other active cancer in your digestive tract (besides the esophageal lesion).
- You do not have any serious health condition (like severe heart or lung disease) or bleeding risk that would make the procedure unsafe.
- You have not had chemotherapy, immunotherapy, or radiation in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of taking tissue samples during endoscopy to check how Barrett’s esophagus is changing. The goal is to improve surveillance, especially for finding early precancer or early cancer changes.
This trial tests two simple, non-surgical methods to look for Barrett's esophagus (a change in the lining of the swallowing tube) and early esophageal cancer. It is for people who are at higher risk or lower risk, but have never had Barrett's or cancer before.
This study aims to screen for Barrett's esophagus in people who are getting a routine colonoscopy but do not have chronic heartburn. It uses a simple, non-invasive cell collection device (EsoCheck) to see if you might have Barrett's esophagus, which can increase the risk of esophageal cancer.
This study tests minimally invasive, sample-based tests during an endoscopy to find Barrett’s esophagus and help sort it from esophageal cancer risk. It may help doctors spot changes earlier and more accurately using less invasive methods than standard tissue testing alone.
This trial tests a device that collects cells from the esophagus using a swallowed capsule, which may detect Barrett's esophagus without a standard endoscopy. It is for people who are already scheduled for an endoscopy.
This study tests a new, less invasive way to detect precancerous changes or early cancer in Barrett's esophagus. It uses a sponge or brush to collect cells from your esophagus during a routine endoscopy, which may help find problems earlier and avoid more invasive procedures.
Hear when a new Barrett Esophagus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.